Which Funding Instrument Should Your Startup Use? A Decision Guide

Five questions decide your funding instrument. Is the round priced or valuation-deferred? Is the company DPIIT-recognised? How big is each cheque? Is the money domestic or foreign? And does the investor want equity risk or a debt floor? Walk the questions in order and the instrument almost always picks itself. This page is the decision guide – with the law behind every branch, and links to the deep-dive guide for whichever instrument you land on.

The decision tree

#QuestionIf YESIf NO
1Is an institutional lead pricing the round now?CCPS, priced round with SHA → CCPS guideContinue ↓
2Deferring valuation – is the company DPIIT-recognised AND is every cheque ₹25 lakh+?Convertible noteCN guideContinue ↓
3Deferring valuation with smaller / mixed cheques?iSAFE on CCPS railsiSAFE guideContinue ↓
4Is the investor a foreign parent/affiliate wanting interim yield?CCD (deductible coupon, FDI-compliant) → CCD sectionContinue ↓
5Founders, family, ESOP exercise, or an angel who wants simplicity?Plain equity with a clean SHAReconsider Q1 – you are probably pricing a round

The overlay questions that veto the tree

Foreign money? Only compulsorily convertible instruments (equity, CCPS, CCD) are FDI; optionally convertible anything is ECB territory. Pricing certificate at or above fair value, FC-GPR in 30 days, sectoral caps, and PN3 approval for land-border investors all apply. CNs are open to foreign investors with Form CN reporting. NRI money? The Schedule IV non-repatriation route gives domestic treatment for every instrument including CNs (Rule 18(4)). Debt with security instead of equity risk? That is venture debt – NCDs, a different animal from all of the above. Government money? SISFS’s market-entry tranche arrives as convertible debentures on its own standard terms – see the government funding guide.

Worked routings

Case 1 – ₹1.2 crore from 6 angels (₹20 lakh each), DPIIT-recognised, no lead: Q1 no → Q2 fails on ticket size (₹20 lakh < ₹25 lakh floor) → iSAFE with a ₹30 crore cap and 20% discount. Alternative: pool via one syndicate SPV writing ₹1.2 crore → a single compliant CN.
Case 2 – ₹8 crore seed, micro-VC lead at ₹40 crore post: Q1 yes → priced CCPS: 1x non-participating preference, broad-based weighted-average anti-dilution, ESOP top-up negotiated against a hiring plan. See the seed guide.
Case 3 – US parent funding its Indian subsidiary ₹15 crore for 30 months of operations: Q4 yes → CCD with a market coupon (deductible at 25.17%), compulsory conversion inside 10 years, FC-GPR on issue. Pure-debt alternative runs on the ECB rulebook – compare in our foreign investment hub.
Case 4 – bridge to Series A, existing investors, ₹3 crore, DPIIT-recognised: Q2 yes (cheques ₹50 lakh–₹1 crore) → CN at 20% discount to the A price, 18-month long-stop, one term set – resist stacking a second note on different terms.

The mistakes this tree prevents

Issuing a CN without DPIIT recognition – the money becomes a deposit; use iSAFE/CCPS instead. Splitting a CN below the ₹25 lakh floor – same problem; pool through an SPV. Optionally convertible instruments to foreign investors – not FDI; you have accidentally borrowed ECB with the wrong paperwork. Full-ratchet anti-dilution for foreign CCPS holders – collides with the FEMA conversion-price floor set at issuance. Plain equity to a large angel with no SHA – no exit rights, no tag-along, future governance friction. Each of these is a real diligence finding we see in Indian Series A processes – cheap to prevent, expensive to cure.

Still between two branches?

My Cloud Accountant will look at your cap table, investors and timeline and confirm the instrument – then paper it correctly the first time.

Talk to an expert

Frequently Asked Questions

Can we mix instruments in one round?

Yes, and it is common: a priced CCPS lead with a CN second-close at the same economics, or CCPS for institutions and iSAFE for small angels. Keep conversion economics aligned across instruments – divergent caps and discounts inside one round create conflict at the next one.

Which instrument is fastest to close?

A CN for a DPIIT startup is the lightest (agreement + board/SR + Form CN if foreign). iSAFE/CCPS and priced CCPS carry the full private-placement sequence – valuation report, PAS-4/PAS-3 – typically 3–5 weeks. Venture debt adds trustee and charge filings.

Does the instrument change my tax as a founder?

Not directly – founder shares are plain equity regardless. Indirectly yes: instrument choice drives dilution timing (notes convert later, at unknown prices), and s.70 of the Income-tax Act 2025 makes conversions tax-neutral for investors, so the cap table you see at the next round reflects economics agreed today.

What should a first-time angel default to?

Whatever the round’s standard is – but check three things: if it is a CN, that DPIIT recognition is live and your cheque clears ₹25 lakh; if an iSAFE, that you understand you become a CCPS shareholder with a maturity-date conversion; if priced CCPS, that the SHA gives you tag-along. And from 8 September 2026, fund-route investing requires accreditation.

Last reviewed: July 2026. Cross-references: Companies Act 2013, FEM (NDI) Rules 2019, Deposit Rules 2014, Income-tax Act 2025.

A decision guide, not advice. Confirm instrument choice with your CA and counsel against your specific cap table and investors.
Scroll to Top